Article
Down syndrome and personalized medicine: changing paradigms from genotype to phenotype to treatment.
Congenital anomalies - 1 Mar 2013
McCabe Linda L, McCabe Edward R B
Abstract excerpt
Personalized Medicine represents a paradigm shift in the conceptual framework of research and clinical care. This shift argues that Down syndrome is a treatable condition, and therefore we must invest in research to improve outcomes. Individuals with Down syndrome have varying levels of increased risk for a number of co-morbidities, including infantile spasms and early onset Alzheimer's disease. We will review...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.